Veterinary Anti-Infectives Market Size, Share, Trends, Growth and Forecast 2032

Veterinary Anti-Infectives Market

Veterinary Anti-Infectives Market By Animal Type (Livestock and Pet), By Drug Class (Antibacterial, Antimicrobial, Antiviral, Antifungal and Antiparasitic Agents), By Mode of Administration (Oral, Parenteral and Topical): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-2510 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 4.86 Billion USD 6.99 Billion 4.11% 2023

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Animal Type
        • 2.1.1.2. Market Attractiveness Analysis, By Drug Class
        • 2.1.1.3. Market Attractiveness Analysis, By Mode Of Administration
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Veterinary Anti-Infectives Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Veterinary Anti-Infectives Market – Animal Type Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Animal Type, 2020 & 2028
    • 4.2. Livestock
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Pet or Companion
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Veterinary Anti-Infectives Market – Drug Class Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Drug Class, 2020 & 2028
    • 5.2. Antibacterial
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Antimicrobial
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Antiviral
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Antifungal
      • 5.5.1. Market Size and Forecast, By Region (USD Million)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Antiparasitic
      • 5.6.1. Market Size and Forecast, By Region (USD Million)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Veterinary Anti-Infectives Market – Mode Of Administration Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By Mode Of Administration, 2020 & 2028
    • 6.2. Oral
      • 6.2.1. Market Size and Forecast, By Region (USD Million)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Parenteral
      • 6.3.1. Market Size and Forecast, By Region (USD Million)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.4. Topical
      • 6.4.1. Market Size and Forecast, By Region (USD Million)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7 Veterinary Anti-Infectives Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.2.2. North America Market Revenue, By Animal Type, 2016 – 2028
      • 7.2.3. North America Market Revenue, By Drug Class, 2016 – 2028
      • 7.2.4. North America Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Animal Type, 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By Drug Class, 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Animal Type, 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By Drug Class, 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Animal Type, 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By Drug Class, 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By Mode Of Administration, 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.3.2. Europe Market Revenue, By Animal Type, 2016 – 2028
      • 7.3.3. Europe Market Revenue, By Drug Class, 2016 – 2028
      • 7.3.4. Europe Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Animal Type, 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By Drug Class, 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Animal Type, 2016 – 2028
        • 7.3.6.2. France Market Revenue, By Drug Class, 2016 – 2028
        • 7.3.6.3. France Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Animal Type, 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By Drug Class, 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Animal Type, 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By Drug Class, 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Animal Type, 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By Drug Class, 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Animal Type, 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By Drug Class, 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By Mode Of Administration, 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.4.2. Asia Pacific Market Revenue, By Animal Type, 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By Drug Class, 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Animal Type, 2016 – 2028
        • 7.4.5.2. China Market Revenue, By Drug Class, 2016 – 2028
        • 7.4.5.3. China Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Animal Type, 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By Drug Class, 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Animal Type, 2016 – 2028
        • 7.4.7.2. India Market Revenue, By Drug Class, 2016 – 2028
        • 7.4.7.3. India Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Animal Type, 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By Drug Class, 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Animal Type, 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By Drug Class, 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Animal Type, 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Drug Class, 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By Mode Of Administration, 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.5.2. Latin America Market Revenue, By Animal Type, 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By Drug Class, 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Animal Type, 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By Drug Class, 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Animal Type, 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By Drug Class, 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Animal Type, 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By Drug Class, 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By Mode Of Administration, 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Animal Type, 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By Drug Class, 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Animal Type, 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By Drug Class, 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Animal Type, 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By Drug Class, 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Animal Type, 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Drug Class, 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By Mode Of Administration, 2016 – 2028
  • Chapter No. 8 Veterinary Anti-Infectives Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
      • 8.2.1. Driving Factor 1 Analysis
      • 8.2.2. Driving Factor 2 Analysis
    • 8.3. Market Restraints
      • 8.3.1. Restraining Factor Analysis
    • 8.4. Market Opportunities
      • 8.4.1. Market Opportunity Analysis
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Technology Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9 Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global Veterinary Anti-Infectives Market: Company Market Share, 2019
      • 9.1.2. Global Veterinary Anti-Infectives Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 9.1.3. Global Veterinary Anti-Infectives Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global Veterinary Anti-Infectives Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10 Company Profiles
    • 10.1. Pfizer Inc
      • 10.1.1. Company Overview
      • 10.1.2. Key Executives
      • 10.1.3. Product Portfolio
      • 10.1.4. Financial Overview
      • 10.1.5. Operating Business Segments
      • 10.1.6. Business Performance
      • 10.1.7. Recent Developments
    • 10.2. Merck and Co Ltd
    • 10.3. Brystul Myers Squibb Company
    • 10.4. Abbott
    • 10.5. Novartis AG
    • 10.6. Johnson and Johnson Services Inc
    • 10.7. Gilead Sciences Inc
    • 10.8. Astellas Pharma Inc
    • 10.9. GlaxoSmithKline plc
    • 10.10. Gilead Sciences
    • 10.11. AbbVie
    • 10.12. Bayer AG
    • 10.13. Boehringer Ingelheim GmbH
    • 10.14. Ceva Santé Animale
    • 10.15. Elanco
  • Chapter No. 11 Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Environmental Change
  • Chapter No. 12 Research Methodology
    • 12.1. Research Methodology
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Component
FIG NO. 2. Market Attractiveness Analysis, By Application
FIG NO. 3. Market Attractiveness Analysis, By End Use Industry
FIG NO. 4. Market Attractiveness Analysis, By Region
FIG NO. 5. Global Veterinary Anti-Infectives Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 6. Impact of COVID-19 Pandemic in North American Countries
FIG NO. 7. Market Revenue Share, By Component, 2020 & 2028
FIG NO. 8. Global Veterinary Anti-Infectives Market for Software, Revenue (USD Million) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Software, By Country, 2020 & 2028
FIG NO. 10. Global Veterinary Anti-Infectives Market for Service, Revenue (USD Million) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Service, By Country, 2020 & 2028
FIG NO. 12. Global Veterinary Anti-Infectives Market Revenue Share, By Application, 2020 & 2028
FIG NO. 13. Global Veterinary Anti-Infectives Market for Marketing, Revenue (USD Million) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Marketing, By Country, 2020 & 2028
FIG NO. 15. Global Veterinary Anti-Infectives Market for Operations, Revenue (USD Million) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Operations, By Country, 2020 & 2028
FIG NO. 17. Global Veterinary Anti-Infectives Market for Finance, Revenue (USD Million) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Finance, By Country, 2020 & 2028
FIG NO. 19. Global Veterinary Anti-Infectives Market for Human Resource, Revenue (USD Million) 2016 – 2028
FIG NO. 20. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Human Resource, By Country, 2020 & 2028
FIG NO. 21. Global Veterinary Anti-Infectives Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 22. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Others, By Country, 2020 & 2028
FIG NO. 23. Global Veterinary Anti-Infectives Market Revenue Share, By End Use Industry, 2020 & 2028
FIG NO. 24. Global Veterinary Anti-Infectives Market for Manufacturing, Revenue (USD Million) 2016 – 2028
FIG NO. 25. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Manufacturing, By Country, 2020 & 2028
FIG NO. 26. Global Veterinary Anti-Infectives Market for Hospitality, Revenue (USD Million) 2016 – 2028
FIG NO. 27. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Hospitality, By Country, 2020 & 2028
FIG NO. 28. Global Veterinary Anti-Infectives Market for BFSI, Revenue (USD Million) 2016 – 2028
FIG NO. 29. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for BFSI, By Country, 2020 & 2028
FIG NO. 30. Global Veterinary Anti-Infectives Market for Retail, Revenue (USD Million) 2016 – 2028
FIG NO. 31. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Retail, By Country, 2020 & 2028
FIG NO. 32. Global Veterinary Anti-Infectives Market for IT & Telecom, Revenue (USD Million) 2016 – 2028
FIG NO. 33. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for IT & Telecom, By Country, 2020 & 2028
FIG NO. 34. Global Veterinary Anti-Infectives Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 35. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Others, By Country, 2020 & 2028
FIG NO. 36. Global Veterinary Anti-Infectives Market Revenue Share, By Region, 2020 & 2028
FIG NO. 37. North America Veterinary Anti-Infectives Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 38. Porter’s Five Forces Analysis for Global Veterinary Anti-Infectives Market
FIG NO. 39. PEST Analysis for Global Veterinary Anti-Infectives Market
FIG NO. 40. Pricing Analysis for Global Veterinary Anti-Infectives Market
FIG NO. 41. Value Chain Analysis for Global Veterinary Anti-Infectives Market
FIG NO. 42. Company Share Analysis, 2019
FIG NO. 43. Radar Determinant Chart, 2019
FIG NO. 44. Company Strategic Developments – Heat Map Analysis
FIG NO. 45. Oracle Corporation Business Segment Revenue Share, 2020 (%)
FIG NO. 46. Oracle Corporation Geographical Segment Revenue Share, 2020 (%)
FIG NO. 47. Market Channels
FIG NO. 48. Marketing Channel Development Trend
FIG NO. 49. Growth in World Gross Product, 2008-2018
FIG NO. 50. Research Methodology – Detailed View
FIG NO. 51. Research Methodology
 


Table Of Tables

List of Tables 

TABLE NO. 1. Global Veterinary Anti-Infectives Market: Snapshot
TABLE NO. 2. Quarterly Veterinary Anti-Infectives Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Veterinary Anti-Infectives Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 6. Global Veterinary Anti-Infectives Market for Software, by Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global Veterinary Anti-Infectives Market for Service, by Region, 2016 – 2028 (USD Million)
TABLE NO. 8. Global Veterinary Anti-Infectives Market for Marketing, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9. Global Veterinary Anti-Infectives Market for Operations, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10. Global Veterinary Anti-Infectives Market for Finance, by Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global Veterinary Anti-Infectives Market for Human Resource, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12. Global Veterinary Anti-Infectives Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 13. Global Veterinary Anti-Infectives Market for Manufacturing, by Region, 2016 – 2028 (USD Million)
TABLE NO. 14. Global Veterinary Anti-Infectives Market for Hospitality, by Region, 2016 – 2028 (USD Million)
TABLE NO. 15. Global Veterinary Anti-Infectives Market for BFSI, by Region, 2016 – 2028 (USD Million)
TABLE NO. 16. Global Veterinary Anti-Infectives Market for Retail, by Region, 2016 – 2028 (USD Million)
TABLE NO. 17. Global Veterinary Anti-Infectives Market for IT & Telecom, by Region, 2016 – 2028 (USD Million)
TABLE NO. 18. Global Veterinary Anti-Infectives Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 19. Global Veterinary Anti-Infectives Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 20. North America Veterinary Anti-Infectives Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 21. North America Veterinary Anti-Infectives Market Revenue, By Component, 2016 – 2028 (USD Million)
TABLE NO. 22. North America Veterinary Anti-Infectives Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 23. North America Veterinary Anti-Infectives Market Revenue, By End Use Industry, 2016 – 2028 (USD Million)
TABLE NO. 24. U.S. Veterinary Anti-Infectives Market Revenue, By Component, 2016 – 2028 (USD Million)
TABLE NO. 25. U.S. Veterinary Anti-Infectives Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 26. U.S. Veterinary Anti-Infectives Market Revenue, By End Use Industry, 2016 – 2028 (USD Million)
TABLE NO. 27. Canada Veterinary Anti-Infectives Market Revenue, By Component, 2016 – 2028 (USD Million)
TABLE NO. 28. Canada Veterinary Anti-Infectives Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 29. Canada Veterinary Anti-Infectives Market Revenue, By End Use Industry, 2016 – 2028 (USD Million)
TABLE NO. 30. Mexico Veterinary Anti-Infectives Market Revenue, By Component, 2016 – 2028 (USD Million)
TABLE NO. 31. Mexico Veterinary Anti-Infectives Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 32. Mexico Veterinary Anti-Infectives Market Revenue, By End Use Industry, 2016 – 2028 (USD Million)
TABLE NO. 33. Drivers for the Veterinary Anti-Infectives Market: Impact Analysis
TABLE NO. 34. Restraints for the Veterinary Anti-Infectives Market: Impact Analysis
TABLE NO. 35. Major Buyers of Veterinary Anti-Infectives
TABLE NO. 36. Distributors/Traders List of Veterinary Anti-Infectives
TABLE NO. 37. Global Veterinary Anti-Infectives Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 38. Global Veterinary Anti-Infectives Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)

Methodology

FrequentlyAsked Questions

Veterinary anti-infectives are drugs used to treat infections in animals. They include antibiotics, antivirals, and antifungal medications.

The global veterinary anti-infectives market is expected to be driven by the rising livestock population, pet healthcare spending, and demand for disease prevention and treatment.

According to study, the global veterinary anti-infectives market size was worth around USD 4.86 Billion in 2023 and is predicted to grow to around USD 6.99 Billion By 2032.

The global veterinary anti-infectives market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 4.11% during the forecast period from 2024-2032.

The global veterinary anti-infectives industry is projected to be challenged by Key challenges include antimicrobial resistance, strict regulatory controls, and reduced antibiotic use policies. High R&D costs and limited reimbursement affect profitability.

The Opportunities lie in companion animal healthcare growth, livestock disease control, and responsible antibiotic use. New formulations and regulatory-compliant products expand market reach will offer significant growth opportunities in the veterinary anti-infectives market.

Targeted antimicrobial formulations; reduced antibiotic resistance strategies; growth in companion animal therapeutics are the emerging trends and innovations impacting the veterinary anti-infectives market.

The global veterinary anti-infectives market is expected to be led by North America during the forecast period.

Some of the prominent players operating in the global veterinary anti-infectives market are; Pfizer Inc, Merck and Co., Ltd, Brystol Myers Squibb Company, Abbott, Novartis AG, Johnson and Johnson Services Inc, Gilead Sciences, Inc, Astellas Pharma Inc, GlaxoSmithKline plc, Gilead Sciences, AbbVie, Bayer AG, Boehringer Ingelheim GmbH, Ceva Santé Animale, Elanco and among others and others.

The report explores crucial aspects of the veterinary anti-infectives market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.

  • zion payment modes

List of Contents

What is the Market size of the Market Industry?Market Overview Growth FactorsReport ScopeSegmentation AnalysisDrug Segment Analysis PreviewRegional Analysis Preview Key Market Players Competitive Landscape.The global veterinary anti-infectivesis segmented as follows:

HappyClients